Summary
Retinoids, the analogs of vitamin A, are active in vitro and in vivo against squamous cell carcinoma in animals and against certain epithelial precancers and cancers in humans. These data led us to design a prospective, multi-institutional, randomized phase II trial of isotretinoin in advanced head and neck squamous cell carcinoma. We randomly assigned 40 patients to receive isotretinoin or methotrexate, the best-studied and most active single agent for this disease. Overall, the study patients had extremely poor prognoses, i.e., low performance statuses and recurring disease after surgery and/or irradiation. Three objective responses (16%), including one complete response, occurred in the 19 evaluable isotretinoin-treated patients. Only one minor response (5%) occurred in the methotrexate-treated group. Toxicity occurred with both drugs, but was manageable and never life threatening in the retinoid group. These results and the established activity of retinoids in oral leukoplakia (a precursor of head and neck cancer) indicate the need for further study of this class of drugs in head and neck cancer.
Similar content being viewed by others
References
Hong WK, Bromer R: Chemotherapy in head and neck cancer. New Engl J Med 308:75–79, 1983
Al-Sarraf M: Chemotherapy strategies in squamous cell carcinoma of the head and neck. CRC Crit Rev Oncol Hematol 1:323–355, 1984
Million RR, Cassisi NJ, Wittes RE: Cancer of the head and neck. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology. JB Lippincott Company, Philadelphia, 1985, pp 407–506
Jacobs C, Wolf GT, Makuch RW, Vikram B: Adjuvant chemotherapy for head and neck squamous carcinoma. (Abstr) Proc Am Soc Clin Oncol 3:182, 1984
Hong WK, Doos WG: Chemoprevention of head and neck cancer. Otolaryngol Clin North Am 18:543–549, 1985
Bollag W: Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1:860–863, 1983
Sporn MB, Roberts AB: Role of retinoids in differentiation and carcinogenesis. JNCI 73:1381–1387, 1984
Sporn MD, Roberts AB, Roche NS, Kagechika H, Shudo K: Mechanism of action of retinoids. J Am Acad Dermatol 15:756–764, 1986
Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33–91, 1980
Lippman SM, Kessler JF, Meyskens Jr FL: Retinoids as preventive and therapeutic anticancer agents (part I). Cancer Treat Rep 71:391–405, 1987
Lippman SM, Kessler JF, Meyskens Jr FL: Retinoids as preventive and therapeutic anticancer agents (part II). Cancer Treat Rep 71:493–515, 1987
Reiss M, Pitman SW, Sartorelli AC: Modulation of the terminal differentiation of human squamous carcinoma cells in vitro by all-trans-retinoic acid. JNCI 74:1015–1023, 1985
Huang CC: Effect of retinoids on the growth of squamous cell carcinoma of the palate in rats. Am J Otolaryngol 7:55–57, 1986
Burge-Bottenbley A, Shklar G: Retardation of experimental oral cancer development by retinyl acetate. Nutr Cancer 5:121–129, 1983
Koch HF: Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Maxillofac Surg 6:59–63, 1978
Koch HF: Effect of retinoids on precancerous lesions of oral mucosa. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids: Advances in Basic Research and Therapy. Springer-Verlag, Berlin, 1981, pp 307–312
Cordero AA, Allevato MAJ, Barclay CA, Traballi CA, Donatti LB: Treatment of linchen planus and leukoplakia with the oral retinoid Ro 10–9359. In: Orfanos CE, BraunFalco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids: Advances in Basic Research and Therapy. Springer-Verlag, Berlin, 1981, pp 273–278
Raque CJ, Biondo RV, Keeran MG, Honeycutt WM, Jansen GT: Snuff dippers keratosis (snuff-induced leukoplakia). South Med J 68:565–568, 1975
Shah JP, Strong EW, Decosse JJ, Itri L, Sellers P: Effect of retinoids on oral leukoplakia. Am J Surg 146:466–470, 1983
Alberts DS, Coulthard SW, Meyskens Jr FL: Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (Accutane). J Biol Response Mod 5:124–128, 1986
Bichler E: The role of aromatic retinoid in treatment of laryngeal keratinizing disorders and dysplasias. In: Spitzy KH, Karrer K (eds) Proceedings of the 13th International Congress of Chemotherapy. VH Egermann, Vienna, 1983, pp 201–229
Kessler JF Meyskens Jr FL, Levine N, Lynch PJ, Jones SE: Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1:1345–1347, 1983
Kessler JF, Jones SE, Levine N, Lynch PJ, Booth AR, Meyskens Jr FL: Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol 123:201–204, 1987
Lippman SM, Meyskens Jr FL: Treatment of advanced squamous cell carcinoma of the skin isotretinoin. Ann Intern Med107:499–501, 1987
Meyskens Jr FL, Gilmartin E, Alberts DS, Levine NS, Brooks R, Salmon SE, Surwit EA: Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 66:1315–1319, 1982
Grose WE, Lehane DE, Dixon DO, Fletcher WS, Stuckey WJ: Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a southwest oncology group study. Cancer Treat Rep 69:577–581, 1985
Lehane DE, Lane M, Stuckey WJ: A comparison of methotrexate (m), methylCCNU (mc) and bleomycin (b) in patients with advanced squamous cell carcinoma of the head and neck (H&N) region; a southwest oncology group study (Abstr). Proc Am Soc Clin Oncol 21:331, 1980
Meyskens Jr FL, Goodman GE, Alberts DS: 13-cis-Retinoic Acid: Pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. CRC Crit Rev Oncol Hematol 3:75–101, 1985
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P, Strong S: 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505, 1986
Besa EC, Abrahm JL, Nowell PC: Increased survival in myelodysplastic syndrome (MDS) patients on high dose long term 13 cis-retinoic acid (RA); decrease of RA toxicity with alpha-tocopherol (AT) (abstract). Proc Am Soc Clin Oncol 6:150, 1987
Sahai A, Feuerstein N, Cooper HL, Salomon DS: Effect of epidermal growth factor and 12–0-tetradecanoylphorbol-13-acetate on the phosphorylation of soluble acidic proteins in A431 epidermoid carcinoma cells. Cancer Res 46:4143–4150, 1986
Behzadian MA, Shimuzu N: Variant of A431 cells isolated by ricin A-conjugated monoclonal antibody directed to EGF receptor: phosphorylation of EGF receptor and phosphatidylinositol. Somatic Cell Mol Genet 11:579–591, 1985
Komiyama S, Hiroto I, Ryu S, Nakashima T, Kuwano M, Endo H: Synergistic combination therapy of 5-fluorouracil, vitamin A, and cobalt-60 radiation upon head and neck tumors. Oncology 35:253–257, 1978
Thatcher N, Blackledge G, Crowther D: Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with Adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin A. Cancer 46:1324–1328, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lippman, S.M., Kassler, J.F., Al-Sarraf, M. et al. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs 6, 51–56 (1988). https://doi.org/10.1007/BF00170781
Issue Date:
DOI: https://doi.org/10.1007/BF00170781